Gengshen Mo
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A Sweet and Stable Strike: Multivalent Glucosylated Gd-DOTBA Conjugate with Ultrahigh Relaxivity for Targeted MRI of Aggressive Cancers.
Journal: Journal of medicinal chemistry
Published: July 08, 2026
Dual-Site Chiral Engineering of a Fully Alkyl-Substituted Gd-DOTA Yields a High-Performance and Safe Hepatobiliary MRI Contrast Agent.
Journal: Journal of medicinal chemistry
Published: April 24, 2026
New Chiral Pyclen-Based Gadolinium(III) Complexes: Advancing Stability, Relaxivity, and Water Exchange for Improved Magnetic Resonance Imaging Probes.
Journal: Journal of medicinal chemistry
Published: July 10, 2025
Design of Mn(1,4-DO2A) derivatives as stable and inert contrast agents for magnetic resonance imaging.
Journal: Communications chemistry
Published: April 10, 2025
Chiral Strategy for Developing High-Performance Polymeric Gadolinium-Based MRI Contrast Agents for Vascular and Tumor Imaging.
Journal: Chemical & biomedical imaging
Published: February 04, 2025
Rational Design of Mono-Substituted Gd-DOTA as Highly Stable and Efficient MRI Contrast Agents for Hepatobiliary and Inflammation Imaging.
Journal: Journal of medicinal chemistry
Published: August 27, 2024
Chiral Pyclen-Based Heptadentate Chelates as Highly Stable MRI Contrast Agents.
Journal: Inorganic chemistry
Published: April 20, 2024
Chiral Gd-DOTA as a Versatile Platform for Hepatobiliary and Tumor Targeting MRI Contrast Agents.
Journal: Journal of medicinal chemistry
Published: October 19, 2023
Preoperative T staging of advanced gastric cancer using double contrast-enhanced ultrasound.
Journal: Ultraschall in der Medizin (Stuttgart, Germany : 1980)
Published: June 30, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026